LISSENCEPHALY THERAPEUTIC AGENT
    1.
    发明申请
    LISSENCEPHALY THERAPEUTIC AGENT 有权
    LISSENCEPHALY治疗剂

    公开(公告)号:US20160250276A1

    公开(公告)日:2016-09-01

    申请号:US15074142

    申请日:2016-03-18

    Inventor: Shinji Hirotsune

    CPC classification number: A61K38/05 A61K9/0019 A61K9/0053 A61K31/00

    Abstract: An object of the present invention is to provide a medicament and method for treating lissencephaly patients. The present invention provides a lissencephaly therapeutic or preventive agent comprising a compound represented by the general formula (I): wherein R1 is lower alkyl substituted with lower alkoxy, lower alkyl substituted with a heterocyclic group, a heterocyclic group, or a group represented by the formula (IIa): wherein R4 is lower alkyl, R3 is lower alkylene, and m is an integer of 1 to 6; R2 is lower alkyl optionally substituted with phenyl; and R3 is lower alkyl optionally substituted with halogen, lower alkoxy, or phenyl; condensed polycyclic hydrocarbon; or hydrogen.

    Abstract translation: 本发明的一个目的是提供一种用于治疗失精症患者的药物和方法。 本发明提供一种包含由通式(I)表示的化合物的解散性治疗剂或预防剂:其中R 1为被低级烷氧基取代的低级烷基,被杂环基取代的低级烷基,杂环基或由 式(IIa):其中R 4为低级烷基,R 3为低级亚烷基,m为1至6的整数; R2是任选被苯基取代的低级烷基; 且R 3为任选被卤素,低级烷氧基或苯基取代的低级烷基; 稠合多环烃; 或氢气。

    Lissencephaly therapeutic agent
    2.
    发明授权
    Lissencephaly therapeutic agent 有权
    放射治疗剂

    公开(公告)号:US09539298B2

    公开(公告)日:2017-01-10

    申请号:US15074142

    申请日:2016-03-18

    Inventor: Shinji Hirotsune

    CPC classification number: A61K38/05 A61K9/0019 A61K9/0053 A61K31/00

    Abstract: An object of the present invention is to provide a medicament and method for treating lissencephaly patients. The present invention provides a lissencephaly therapeutic or preventive agent comprising a compound represented by the general formula (I): wherein R1 is lower alkyl substituted with lower alkoxy, lower alkyl substituted with a heterocyclic group, a heterocyclic group, or a group represented by the formula (IIa): wherein R4 is lower alkyl, R3 is lower alkylene, and m is an integer of 1 to 6; R2 is lower alkyl optionally substituted with phenyl; and R3 is lower alkyl optionally substituted with halogen, lower alkoxy, or phenyl; condensed polycyclic hydrocarbon; or hydrogen.

    Abstract translation: 本发明的一个目的是提供一种用于治疗失精症患者的药物和方法。 本发明提供一种包含由通式(I)表示的化合物的解散性治疗剂或预防剂:其中R 1为被低级烷氧基取代的低级烷基,被杂环基取代的低级烷基,杂环基或由 式(IIa):其中R 4为低级烷基,R 3为低级亚烷基,m为1至6的整数; R2是任选被苯基取代的低级烷基; 且R 3为任选被卤素,低级烷氧基或苯基取代的低级烷基; 稠合多环烃; 或氢气。

Patent Agency Ranking